<sup>177</sup> Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II StudyAmar U. Kishan, Jérémie Calais, R. Nabong et al.|Journal of Clinical Oncology|2025Cited by 24
Acute Toxicity Following Dose-Escalated MRI-Guided SBRT vs. Adapted Dose-Painted MRI-Guided SBRT: A Pooled Comparison of Prospective TrialsP.T. Courtney, A.U. Kishan, Jonathan Pham et al.|International Journal of Radiation Oncology*Biology*Physics|2025Cited by 0